Shuzi Chen
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Retraction notice to "Metabolic effects and clinical outcomes of olanzapine in schizophrenia: A systematic review and meta-analysis" [Heliyon 10 (2024) e40424].
Journal: Heliyon
Published: August 12, 2026
A clinical prediction model for schizophrenia based on machine learning algorithms.
Journal: Frontiers in medicine
Published: October 17, 2025
Advances and Challenges in Depression Marker Research.
Journal: Neuropsychiatric disease and treatment
Published: March 12, 2025
A Clinical Risk Prediction Model for Depressive Disorders Based on Seven Machine Learning Algorithms.
Journal: International journal of general medicine
Published: March 03, 2025
Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive Disorder.
Journal: Nutrients
Published: February 16, 2023
Consensus on potential biomarkers developed for use in clinical tests for schizophrenia.
Journal: General psychiatry
Published: October 22, 2021
Research Progress on the Correlation Between Epigenetics and Schizophrenia.
Journal: Frontiers in neuroscience
Published: March 31, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026